FINGOLIMOD vs PONVORY

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated June 7, 2026·How we rate

Possible drug interaction. FINGOLIMOD and PONVORY are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	FINGOLIMOD	PONVORY
Rating	New	New
Pharmacy pays	~$126.02 /30	—
Type	RX	RX
Active ingredient	FINGOLIMOD	PONESIMOD
Manufacturer	Standard Chem and Pharm Co Ltd	Vanda Pharms Inc
Dosage forms	Capsule	Tablet, Kit
Drug class	Sphingosine 1-Phosphate Receptor Modulator	Sphingosine 1-Phosphate Receptor Modulator
Boxed warning	None	None
Half-life	about 6 to 9 days (average apparent terminal half-life)	—
Treats	Relapsing-Remitting Multiple Sclerosis	Relapsing-Remitting Multiple Sclerosis

fingolimod ponvory

Rating

New

Pharmacy pays

~$126.02 /30

—

Type

Active ingredient

FINGOLIMOD

PONESIMOD

Manufacturer

Standard Chem and Pharm Co Ltd

Vanda Pharms Inc

Dosage forms

Capsule

Tablet, Kit

Drug class

Sphingosine 1-Phosphate Receptor Modulator

Boxed warning

None

Half-life

about 6 to 9 days (average apparent terminal half-life)

—

Treats

Relapsing-Remitting Multiple Sclerosis

Frequently asked questions

What is the difference between Fingolimod and Ponvory?

Fingolimod contains Fingolimod, while Ponvory contains Ponesimod — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.